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Ameloblastoma is a benign epithelial odontogenic 
tumor and is the most commonly encountered odontogenic 
tumor in the jaws. Histologically, ameloblastomas occur 
in different patterns, including plexiform pattern and 
follicular pattern. “Hybrid “ lesion of ameloblastoma is a 
tumor variant in which histologically, areas of follicular or 
plexiform ameloblastoma coexist with characteristic areas of 
ameloblastoma exhibiting pronounced stromal desmoplasia 
(desmoplastic ameloblastoma). The purpose of this article 
is to present a case of “hybrid” lesion of desmoplastic 
ameloblastoma (AD) and conventional, and investigate 
extracellular matrix proteins such as tenascin, fibronectin, 
and type I collagen.
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INTRODUCTION
Ameloblastomas are a common benign neoplasia 
of maxillary bones, originated from the remains of the 
dental plate. Histologically, it occurs in many patterns, 
including the types: follicular, plexiform, acanthomatous, 
of granular cells, of basal cells and the desmoplastic. The 
latter was initially described by Eversole et al.1, in 1984. 
It is usually characterized by a pronounced stroma colla-
genization, which is permeated by small islets and cords 
of the tumoral odontogenic epithelium. It also bears an 
uncommon radiographic aspect and a marked difference 
in anatomical location when compared to the conventional 
ameloblastoma.
In recent years, the literature has described “hybrid 
lesions” of desmoplastic ameloblastoma and conventional 
ameloblastoma, that are microscopically characterized by 
presenting areas of follicular or plexiform ameloblastoma 
coexisting with areas of desmoplastic ameloblastoma2,3.
Moreover, many studies have shown the impor-
tance of the extracellular matrix (ECM) in the modulation 
of neoplastic cell behavior and in the histomorphologic 
aspects of tumoral cells4. Thus, the present study aims at 
reporting a case of a “hybrid” desmoplastic and conventio-
nal ameloblastoma (AB) in the mandible, highlighting the 
immune-histochemical findings related to the expression 
of tenascin and fibronectin proteins and type I collagen 
in the stroma of the lesion.
CASE REPORT
A 36 year old man came for dental care complaining 
of a painless volume increase within his mouth. Extra-oral 
clinical exam showed a slight volume increase on the 
right side of the mandible. Inside the mouth we found a 
hard volume increase going from the inferior cusp all the 
way to the pre-molar region covered by normal-looking 
mucosa. The dental units involved were somewhat shif-
ted, with slight mobility and without pulp involvement. 
Radiographic exam revealed a radiolucent area of ill-
defined outline in the region between units 33 and 37. 
Under clinical suspicion of ameloblastoma, we carried 
out an incisional biopsy of which the histopathological 
diagnosis was confirmed. The lesion was then surgically 
removed by block resection, preserving the lower border 
of the mandible. The subsequent histopathology exam 
established the diagnosis of a hybrid desmoplastic and 
follicular ameloblastoma lesion. 
For the immunehistochemical technique we prepa-
red 3µm sections and submitted those to the streptavidine 
biotin method. The antibodies used in this study, their 
sources, dilutions and protocols are listed on Table 1. The 
cross sections were submitted to antigenic recovery, using 
1% pepsin (1.0 g of pepsin in 100ml of 10% chloridric acid 
solution in pH of 1.8 for 2 hours at 37oC) and steam heat. 
We also included proper positive and negative controls. 
Diaminobenzidine was used as a chromogen and the cross 
sections were counter dyed by Mayer’s hematoxylin. 
Histopathology findings
The histopathology exam showed areas of des-
moplastic and follicular ameloblastoma. In the former 
we observed tumoral epithelial islets spread in a densely 
collagenized connective stroma (Figure 1). These tumoral 
islets, which seemed to be compressed, were made up 
of cuboid or spindle-shaped cells showing cellular peri-
phery in palisade absent. The second histology subtype 
was represented by epithelial islets of which peripheral 
cells were distributed in palisade, similar to the amelo-
blastomas of the enamel organ (Figure 1). The cells in 
the central region were similar to the stellar reticulum of 
the enamel organ. Often times these cell arrangements 
showed cystic degeneration and, eventually, squamous 
metaplasia. The stroma was less dense and made up of 
scarce lymphocytes.
Figure 1. Connective stroma densely collagenized and permeated by 
compressed epithelial neoplastic islets, as well as by epithelial islet with 
peripheral cells arranged in palisade (H/E, 40x).
Immune-histochemical findings
Tenascin
The tenascin marking pattern was of the fibrillar 
type, with intensity varying from mild to moderate in the 
stroma corresponding to the follicular ameloblastoma. In 
the stroma corresponding to the DA we did not observe 
markings for this immune protein in the ECM (Figure 2). In 
the follicular ameloblastoma tumoral islets, which showed 
cystic degeneration, we saw one intense and homogenous 
immune marking, sometimes linear, outlining the cystic 
spaces. Sometimes these tumoral islets that showed squa-
mous metaplasia were also immune marked. 
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Fibronectin
All along the tumoral stroma, of the follicular amelo-
blastoma or the desmoplastic, there was a strong immune 
marking distributed in a fibrillar pattern (Figure 3). On the 
epithelium/mesenchyma interface we noticed a strong 
linear marking, specially in the areas that corresponded 
to the conventional ameloblastoma. Some epithelial cells 
in the tumoral islets under cystic degeneration also ex-
pressed this protein. 
Sometimes, on the epithelium/mesenchyma interface, we 
noticed intense linear immune marking, specially on the 
areas corresponding to the conventional ameloblastoma. 
Moreover, we noticed lack of type I collagen inside these 
tumoral cells. 
Figure 2. Lack of immune marking for tenascin in the lesion stroma 
(streptavidine biotin, 40x).
Figure 3. Fibrillar fibronectin pattern in the tumor stroma (streptavidine 
biotin, 40x).
Collagen I
Similar to fibronectin, all along the tumoral stroma 
of the hybrid lesion in the desmoplastic ameloblastoma, 
there was an intense immune marking for this ECM protein, 
in a fibrillar pattern involving the tumoral islets (Figure 4). 
Figure 4. Strong affinity with type I collagen in a fibrillar pattern on the 
desmoplastic stroma of the lesion (streptavidine biotin, 40x).
DISCUSSION
In the literature we noticed that the DA represented 
the odontogenic tumor of the least incidence. Among 89 
cases of ameloblastomas studied by Takata et al.5, seven 
(7.9%) were diagnosed as DA; and only (1.1%) as “hybrid 
lesion”. In Japan, the DA was responsible for 5.3% of all 
the cases of intraosseus ameloblastomas diagnosed in 27 
years6. The clinical aspects reported in the present case 
match those mentioned in the literature, where the DA is 
presented as a painless volume increase on the face and 
with a slight predilection for males5,7.
Radiographically, the DA presents aspects which 
are very different from those of the conventional amelo-
blastoma, characterizing itself as a radiolucent lesion of 
unclear limits, resembling soap bubbles7. In many cases, 
the lesion appears as a radiolucent area with radiopacity 
points that mimic fibro-osseous lesions8.
Since it presents its own clinical and radiographic 
characteristics, the desmoplastic ameloblastoma (DA) has 
been considered by some authors as a clinical and patho-
logical distinct entity2,5. This was recently confirmed by the 
World Health Organization (WHO), of which classification 
organized the ameloblastomas in solid, extraosseous, des-
moplastic and unicystic9.
The histopathological characteristics described for 
the present case are in agreement with the diagnostic 
criteria established for a “hybrid lesion” of desmoplastic 
and conventional ameloblastomas according to Waldron 
and El-mofty2. Thus, such lesion is characterized as 
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containing DA areas in association with typical areas of 
follicular ameloblastoma. The areas corresponding to the 
desmoplastic variant is characterized by small nests and 
cords of odontogenic tumoral epithelium within an abun-
dant stroma densely collagenized, and this makes those 
tumoral islets to seem compressed. The peripheral cells 
lose that characteristic that is so similar to ameloblasts with 
polarity inversion. Moreover, the central portion of these 
tumoral islets may present hypercellularity, with occasional 
squamous metaplasia and central keratinization foci8. In 
the latter, we must include the differential diagnosis of 
odontogenic squamous tumor9. Other tumors such as the 
odontogenic fibroma must also be considered in the DA 
differential diagnosis7.
In the present case we did not observe an exuberant 
inflammatory reaction, although one of the alternatives 
used to justify the desmoplasia would be the phenomena 
accruing from inflammation.
We know that the most important characteristic of 
a DA is the extensive collagenization present in the lesion 
stroma, also called desmoplasia1,2,5,10. It has been proposed 
that such phenomenon originates from a new protein syn-
thesis in the extracellular matrix11. Such components play a 
fundamental role in the support, adhesion, migration and 
differentiation of tumoral cells, interfering on the behavior 
and modulation of these cells12,13. Thus, we investigated 
the distribution of tenascin, fibronectin and type I collagen 
in the case hereby reported. 
Tenascin is a protein from the extracellular matrix 
with a very restrict distribution pattern. It is expressed 
during embryogenesis, specially in the areas of epithe-
lium-mesenchyma interaction14. In cases of ameloblastoma 
and adenomatoid odontogenic tumors, tenascin is mainly 
located on the parenchyma-stroma interface, suggesting an 
important participation of this protein in the relationship 
between the tumoral cells and the adjacent connective 
tissue12,13. In the case hereby reported, having tenascin only 
in the areas corresponding to the follicular ameloblastoma 
could explain the more aggressive behavior of this histolo-
gic pattern, since tenascin has been observed in unstable 
environments such as the ones created by neoplasias4. 
The tumoral islets are also positive for tenascin, specially 
in those areas that show some cystic degeneration. Such 
finding was also reported by Mori et al.12 and Medeiros13, 
who related the immune-location of this protein to the 
mechanisms that form and expand cystic spaces. 
Fibronectin represents an adhesion protein of high 
molecular weight, of which distribution follows that of 
lose connective tissue. Its presence has been associated 
to cellular functions such as adhesion, migration, prolife-
ration and differentiation, being related to important mo-
ments of embryogenesis, tissue development and healing. 
During odontogenesis, it interferes on the maturation of 
odontoblasts14.
In ameloblastomas, fibronectin is produced by the 
cells present in the tumoral stroma14. Its distribution is 
relatively uniform in the stroma of many histologic types 
of ameloblastoma. Its distribution is relatively uniform in 
the stroma of various types of ameloblastoma, with greater 
intensity in the epithelium-mesenchyma interface, except 
in the desmoplastic variant, probably due to the lack of 
similarities with the pre-ameloblasts on the peripheral 
epithelial cells13. A similar aspect was also shown in the 
present case, where fibronectin was strongly marked on 
the epithelium-mesenchyma interface of the tumoral areas 
corresponding to the follicular ameloblastoma. 
Tenascin has been described as capable to modulate 
the action of other molecules in the extracellular matrix, 
affecting cell shape and blocking fibronectin4. Such aspect 
was not observed in our study, having in mind that fibro-
nectin was seen in the areas also marked by tenascin.
Type I collagen is the major structure present in 
skin, tendon and bones, and it is also the main organic 
compound present in dentin15. In desmoplastic amelo-
blastoma, there is an intense immunepositiveness of this 
protein when compared to the other histologic subtypes13. 
In a similar way, type I collagen presented strong immune 
marking in the stroma of the present case, reflecting the 
high grade of this protein present in DAs. 
FINAL COMMENTS
Although tenascin, fibronectin and type I collagen 
participate on the tumoral modulation of the “hybrid lesion” 
follicular and desmoplastic ameloblastoma, the biologic 
mechanism of desmoplasia calls to newer investigations re-
garding the other extracellular matrix components, as well 
as other study methods, in an attempt to understand the 
conspicuous stromal collagenization and its relationship 
with the epithelial component of the lesion. 
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